Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 16783610)

Published in Cancer Causes Control on August 01, 2006

Authors

Lene Drasbek Huusom1, Kirsten Frederiksen, Estrid V S Høgdall, Eva Glud, Lise Christensen, Claus K Høgdall, Jan Blaakaer, Susanne Krüger Kjaer

Author Affiliations

1: Institute of Cancer Epidemiology, Danish Cancer Society/Rigshospitalet, Strandboulevarden 49, DK-2100, Copenhagen, Denmark.

Articles by these authors

Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst (2008) 5.82

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst (2010) 3.88

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr (2003) 2.94

Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ (2010) 2.64

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study. Gynecol Oncol (2006) 2.47

Personality traits and cancer risk and survival based on Finnish and Swedish registry data. Am J Epidemiol (2010) 2.30

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09

Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ (2009) 2.08

Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer (2010) 2.08

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res (2006) 2.08

Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis (2008) 1.89

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73

Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma? J Clin Oncol (2004) 1.68

Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol (2010) 1.68

Primary mucinous carcinoma of the skin. Am J Dermatopathol (2007) 1.66

Body fat and fat-free mass and all-cause mortality. Obes Res (2004) 1.64

Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59

Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect (2008) 1.58

Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: Summary of findings. Eur J Cancer (2008) 1.57

Induced abortions in Danish cancer survivors: a population-based cohort study. J Natl Cancer Inst (2009) 1.56

Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril (2013) 1.53

Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. Am J Hum Genet (2004) 1.49

Early parental death and risk of hospitalization for affective disorder in adulthood. Epidemiology (2013) 1.46

Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study. J Clin Oncol (2007) 1.43

The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol (2011) 1.42

Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet (2009) 1.42

Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol (2009) 1.40

Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev (2007) 1.39

Spontaneous abortion in a Danish population-based cohort of childhood cancer survivors. J Clin Oncol (2008) 1.37

Social inequality and incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: Background, aims, material and methods. Eur J Cancer (2008) 1.37

Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med (2004) 1.37

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36

Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology (2006) 1.36

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Oncol Rep (2007) 1.34

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass. Gynecol Oncol (2012) 1.33

Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol (2009) 1.32

Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev (2005) 1.32

Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol (2011) 1.26

Sample handling for mass spectrometric proteomic investigations of human sera. Anal Chem (2005) 1.23

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Clin Cancer Res (2008) 1.20

Primary mucinous carcinoma of the skin: a population-based study. Int J Dermatol (2008) 1.18

Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer (2011) 1.17

Tobacco smoke and bladder cancer--in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2006) 1.16

Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002. Acta Obstet Gynecol Scand (2008) 1.11

Delayed breast implant reconstruction: is radiation therapy associated with capsular contracture or reoperations? Ann Plast Surg (2012) 1.10

Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery. Acta Obstet Gynecol Scand (2007) 1.09

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study. Cancer (2003) 1.09

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol Rep (2003) 1.09

Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS One (2007) 1.08

Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis (2012) 1.07

Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev (2007) 1.05

Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int J Cancer (2008) 1.04

Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.03

Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand (2006) 1.02

Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. Am J Epidemiol (2008) 1.01

Self-efficacy, adjustment style and well-being in breast cancer patients: a longitudinal study. Qual Life Res (2010) 1.01

GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat Res (2009) 1.00

Maternal smoking predicts the risk of spontaneous abortion. Acta Obstet Gynecol Scand (2006) 1.00

Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. Cancer Res (2008) 1.00

[Primary ovarian cancer. A comparison of registrations in the Danish Cancer Registry and the Pathology Data Bank]. Ugeskr Laeger (2007) 1.00

Risk for breast cancer among women with endometriosis. Int J Cancer (2007) 1.00

Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Neoplasia (2010) 0.99

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas. APMIS (2008) 0.99

A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date. Int J Cancer (2014) 0.99

Family-centred care of children in hospital - a concept analysis. J Adv Nurs (2011) 0.99

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99

Are cancer survivors at an increased risk for divorce? A Danish cohort study. Eur J Cancer (2007) 0.98

Treatment with levodopa and risk for malignant melanoma. Mov Disord (2007) 0.98

Life after gynecologic cancer--a review of patients quality of life, needs, and preferences in regard to follow-up. Int J Gynecol Cancer (2013) 0.97

YKL-40 tissue expression and plasma levels in patients with ovarian cancer. BMC Cancer (2009) 0.97